MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s12185-023-03704-w

Медицинская библиотека · International journal of hematology · 2024

A systematic review and meta-analysis of recombinant human soluble thrombomodulin for the treatment of DIC associated with hematological malignancies.

Kawano Noriaki, Fukatsu Masahiko, Yamakawa Kazuma, Seki Yoshinobu, Wada Hideo, Okamoto Kohji, Ikezoe Takayuki

МетаанализСистематический обзорСтатьяПеревод в очереди

Аннотация

BACKGROUND

Recombinant human soluble thrombomodulin (rhTM) is commonly used in Japan to treat disseminated intravascular coagulation (DIC), but its efficacy compared with other anticoagulants is unclear. We conducted a systematic review and meta-analysis to investigate this issue in DIC patients with hematological malignancies.

METHODS

We searched PubMed, Cochrane, and Scopus for prospective and retrospective studies evaluating the efficacy and safety of rhTM in DIC patients with hematological malignancies between April 2008 and April 2023. We performed a systematic review and meta-analysis evaluating recovery from DIC, hemorrhagic adverse events (AEs), and overall survival (OS).

RESULTS

We analyzed one prospective (64 patients) and seven retrospective studies (209 patients). Use of rhTM was associated with a higher rate of recovery from DIC (OR: 2.25 [1.09-4.63] and 1.98 [1.12-3.50] in prospective and retrospective studies, respectively; same order below) and fewer hemorrhagic AEs (OR: 0.83 [0.30-2.30] and 0.21 [0.08-0.57]). rhTM did not improve OS (OR: 1.06 [0.42-2.66] and 1.72 [0.87-3.39]), although the incidence of hemorrhagic death was lower in the rhTM group (0 of 94 patients).

CONCLUSION

Use of rhTM in patients with hematological malignancy-associated DIC is strongly expected to be effective and safe.

Для цитирования: Kawano Noriaki, Fukatsu Masahiko, Yamakawa Kazuma, Seki Yoshinobu, Wada Hideo, Okamoto Kohji, Ikezoe Takayuki. A systematic review and meta-analysis of recombinant human soluble thrombomodulin for the treatment of DIC associated with hematological malignancies.. International journal of hematology. 2024. DOI: 10.1007/s12185-023-03704-w.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.